Dana Investment Advisors, Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 240 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Dana Investment Advisors, Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$670,380
+16.3%
37,683
-0.6%
0.03%
+47.4%
Q1 2024$576,383
+62.6%
37,895
+82.6%
0.02%
+11.8%
Q4 2023$354,479
-26.3%
20,754
-63.9%
0.02%
-32.0%
Q3 2023$481,193
-47.1%
57,559
+57.1%
0.02%
-44.4%
Q2 2023$909,815
+54.2%
36,627
-6.6%
0.04%
+50.0%
Q1 2023$589,86939,2200.03%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders